Study guide

7.2 Radical Cystectomy & Urinary Diversion

FEBU Part 1 Written European Board of Urology

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Strategy

1.1 FEBU Part 1 Examination Structure & Logistics 1.2 EAU Guidelines Framework & Standard Setting 1.3 Clinical Decision-Making & MCQ Strategy 1.4 Professionalism and Safe Practice

2 Chapter 2: Genitourinary Anatomy & Renal Physiology

2.1 Upper Tract Anatomy & Retroperitoneal Relationships 2.2 Lower Urinary Tract Anatomy & Neuroanatomy 2.3 Renal Physiology, Glomerular Filtration & Acid-Base Balance

3 Chapter 3: Urological Pharmacology & Diagnostic Imaging

3.1 Lower Urinary Tract Pharmacotherapy 3.2 Antimicrobial Stewardship & Perioperative Care 3.3 Diagnostic Modalities: Ultrasound, CT, mpMRI & Nuclear Medicine

4 Chapter 4: Prostate Cancer: Diagnosis & Risk Stratification

4.1 PSA Kinetics, Biomarkers & Risk Assessment 4.2 Multiparametric MRI (PI-RADS) & Biopsy Strategies 4.3 Histopathological Grading (ISUP Gleason) & Staging

5 Chapter 5: Prostate Cancer: Localized & Advanced Management

5.1 Active Surveillance & Watchful Waiting 5.2 Radical Prostatectomy & Radiation Therapy 5.3 Biochemical Recurrence & Salvage Therapies 5.4 Metastatic & Castration-Resistant Prostate Cancer (CRPC)

6 Chapter 6: Bladder Cancer: Non-Muscle Invasive (NMIBC)

6.1 TURBT Technique & Pathological Staging 6.2 EAU Risk Stratification for NMIBC 6.3 Intravesical Chemotherapy & BCG Immunotherapy

7 Chapter 7: Muscle-Invasive Bladder Cancer & Upper Tract Urothelial Carcinoma

7.1 Muscle-Invasive Bladder Cancer (MIBC) Staging & Neoadjuvant Therapy 7.2 Radical Cystectomy & Urinary Diversion 7.3 Upper Tract Urothelial Carcinoma (UTUC)

8 Chapter 8: Renal Cell Carcinoma & Adrenal Neoplasms

8.1 Histological Subtypes, Genetics & Staging of RCC 8.2 Localized RCC: Nephron-Sparing Surgery & Radical Nephrectomy 8.3 Metastatic RCC & Targeted / Immunotherapy Regimens 8.4 Adrenal Masses & Incidentalomas

9 Chapter 9: Testicular Germ Cell Tumours & Penile Cancer

9.1 Testicular Cancer Diagnosis, Staging & Tumour Markers 9.2 Management of Seminoma (Stage I to Metastatic) 9.3 Management of Non-Seminoma (Stage I to Metastatic) 9.4 Penile Cancer: Staging, Organ-Sparing & Lymphadenectomy

10 Chapter 10: Benign Prostatic Hyperplasia & Lower Urinary Tract Symptoms

10.1 BPH Pathophysiology, Natural History & Clinical Evaluation 10.2 Medical Management of Male LUTS / BPO 10.3 Interventional & Surgical Management of BPO

11 Chapter 11: Functional Urology, Incontinence & Neuro-Urology

11.1 Urinary Incontinence in Men and Women, Fistulae & Urethral Diverticula 11.2 Overactive Bladder, Bladder Pain Syndrome & Pelvic Organ Prolapse 11.3 Neurogenic Lower Urinary Tract Dysfunction (NLUTD) 11.4 Urodynamic Studies: Indications, Technique & Interpretation

12 Chapter 12: Urolithiasis: Evaluation & Medical Management

12.1 Stone Pathophysiology & Risk Factors 12.2 Metabolic Evaluation & Dietary/Medical Stone Prevention 12.3 Acute Ureteric Colic & Medical Expulsive Therapy

13 Chapter 13: Endourology & Interventional Stone Management

13.1 Shock Wave Lithotripsy (SWL) 13.2 Ureteroscopy (URS) & Retrograde Intrarenal Surgery (RIRS) 13.3 Percutaneous Nephrolithotomy (PCNL) & Endourological Safety

14 Chapter 14: Infections, Andrology & Male Infertility

14.1 Localised & Systemic UTIs, Pyelonephritis, Urosepsis & Specific Infections 14.2 Prostatitis, Epididymo-Orchitis & Fournier Gangrene 14.3 Male Infertility: Evaluation & Surgical Management 14.4 Erectile Dysfunction, Peyronie Disease, Priapism & Gender-Affirming Surgery

15 Chapter 15: Paediatric Urology, Trauma & Renal Transplantation

15.1 Cryptorchidism, Hypospadias & PUJO 15.2 Vesicoureteral Reflux, Posterior Urethral Valves & Nocturnal Enuresis 15.3 Genitourinary Trauma: Kidney, Bladder & Urethra 15.4 Renal Failure, Dialysis Indications & Renal Transplantation

7.2 Radical Cystectomy & Urinary Diversion

Key Takeaways Explain This Topic AI

Radical cystectomy (RC) with bilateral pelvic lymphadenectomy is the curative surgical standard for localized muscle-invasive bladder cancer and BCG-unresponsive non-muscle-invasive bladder cancer.

Conventional cystoprostatectomy removes bladder/perivesical tissue and prostate/seminal vesicles in men. Female resection may include adjacent reproductive organs and urethra, but eligible patients should be assessed for organ and sexual function preservation with oncologically safe margins.

Perform bilateral standard PLND (external/internal iliac and obturator basins to the common iliac bifurcation). Routine extended PLND to the aortic bifurcation increases morbidity without proven survival benefit; node-count associations do not override the randomized evidence.

A neobladder permits urethral voiding by sphincter relaxation and abdominal pressure. It requires a tumour-free urethral margin, sufficient renal/hepatic reserve and ability to catheterize if needed. Prior high-dose pelvic radiotherapy is a relative contraindication.

Ileal/colonic diversions can cause hyperchloremic normal-anion-gap metabolic acidosis; gastric segments can cause hypokalemic hypochloremic alkalosis. Extensive distal ileal resection raises B12 malabsorption risk: monitor B12 annually and treat deficiency promptly.

Last updated: November 2026

7.2 Radical Cystectomy & Urinary Diversion

Radical cystectomy (RC) combined with bilateral pelvic lymph node dissection (PLND) remains the benchmark curative surgical procedure for localized muscle-invasive bladder cancer (cT2–T4aN0M0) and refractory, BCG-unresponsive high-risk non-muscle-invasive disease. Achieving negative surgical margins, performing an anatomically complete lymphadenectomy, and selecting an appropriate urinary diversion are the core determinants of long-term oncological and functional outcomes.

1. Radical Cystectomy: Anatomical Resection Boundaries

Conventional radical cystectomy removes the bladder and adjacent tissues to achieve negative margins. The extent of urethral and reproductive organ resection is tailored to tumour location and oncological safety; selected patients are eligible for organ- or sexual-function-preserving techniques:

Male Radical Cystoprostatectomy

Resected Organs : Urinary bladder with intact perivesical fat and overlying peritoneal envelope, prostate gland, seminal vesicles, terminal segments of both ureters (at least 2–3 cm above the vesicoureteral junction), and regional pelvic lymph nodes.

Posterior Plane : Dissection proceeds between the anterior rectal wall and the posterior aspect of Denonvilliers' fascia to prevent rectal injury.

Apex & Urethral Margin : The puboprostatic ligaments are divided, and the dorsal venous complex is controlled. The urethra is transected cleanly at the prostatic apex. A tumour-free urethral transection margin is essential for a neobladder. Frozen section is used to assess it; EAU allows omission in men with a negative preoperative prostatic urethral biopsy.

Female Cystectomy and Pelvic Organ Preservation

Conventional Extent : Bladder and perivesical tissue, distal ureters, regional nodes and, as required, urethra, adjacent vagina, uterus/cervix and adnexa. Anterior exenteration is the traditional extensive operation, rather than a requirement to remove every listed organ in all women.

Organ Preservation : EAU recommends sexual organ preservation in eligible women when no tumour involves the area to be retained. Preserving ovaries before menopause maintains endocrine function; preserving vagina, uterus/supports and nerves can improve function. Urethral preservation for a neobladder requires appropriate bladder-neck/urethral assessment and a negative urethral margin.

Distal Ureteral Margins

Both ureters must be mobilized with minimal adventitial stripping to preserve their delicate longitudinal blood supply (derived from the renal, gonadal, and common iliac branches). Use ureteric frozen sections selectively , particularly when CIS or suspicious ureteric disease raises concern; routine use in every patient is not established. If a margin is involved, consider further resection while preserving viable ureter and planning definitive management. Negative frozen sections do not eliminate later upper-tract recurrence from urothelial field disease.

2. Pelvic Lymph Node Dissection (PLND) Templates

Bilateral standard PLND is an integral part of RC for staging and regional disease control. Extending it routinely does not improve survival: SWOG S1011 found five-year DFS 56% versus 60% with extended versus standard dissection, with more grade 3–5 events ( 54% versus 44% ). Current EAU guidance recommends the standard template. Inferior mesenteric artery

  • └─ Cranial limit of SUPER-EXTENDED PLND
  • Aortic bifurcation
  • └─ Cranial limit of EXTENDED PLND
  • Adds common iliac / presacral basins to the standard field
  • Common iliac artery bifurcation
  • └─ Cranial limit of STANDARD bilateral PLND
  • External iliac + internal iliac (hypogastric) + obturator basins
  • Dissection Templates

Limited PLND : A restricted true-pelvic dissection that omits deep obturator tissue in the EAU definition; terminology varies between series. It is less comprehensive than the recommended standard template.

Standard PLND : Encompasses the external iliac, internal iliac (hypogastric), and obturator nodal basins bilaterally:

Proximal boundary : Bifurcation of the common iliac artery.

Distal boundary : Deep circumflex iliac vein, femoral canal, and the lymph node of Cloquet.

Lateral boundary : Genitofemoral nerve.

Medial boundary : Ureter.

Deep dissection : Include deep obturator nodal tissue while preserving the obturator nerve and pelvic vessels.

Extended PLND : Extends proximally above the common iliac bifurcation to include the common iliac nodes and the presacral nodes up to the aortic bifurcation.

Super-Extended PLND : Extends cranial to the aortic bifurcation up to the origin of the inferior mesenteric artery (IMA) .

Prognostic Significance of Lymph Node Parameters

Total Node Yield : Yield depends on the anatomical template and pathological processing. Observational associations with survival do not establish a universal 15–20-node minimum or justify routine extended dissection; perform a complete standard template.

Lymph Node Density (LND) : Defined as the ratio of positive lymph nodes to the total number of nodes excised. An LND ≤ \le ≤ 20% has been associated with better outcomes than >20% in node-positive cohorts; this is a prognostic association, not a separate TNM category or automatic treatment rule.

Extranodal Extension (ENE) : Penetration of tumor through the nodal capsule into perinodal fat is an adverse prognostic feature. Adjuvant decisions also require pTNM stage, previous therapy, fitness and applicable drug eligibility (see section 7.1).

3. Types of Urinary Diversion

Urinary diversions are categorized by functional mechanism into incontinent conduits , continent cutaneous reservoirs , and orthotopic neobladders .

Incontinent Cutaneous Diversions

Ileal Conduit (Bricker) : The most widely utilized diversion worldwide (>70% of cases). A 15 to 20 cm segment of terminal ileum is isolated approximately 15 to 20 cm proximal to the ileocecal valve, preserving blood supply and as much distal absorptive ileum as possible. Bowel continuity is restored with an enteroenteric anastomosis; B12 surveillance remains necessary. The ureters are anastomosed to the proximal end of the conduit using separate spatulated end-to-side anastomoses (Bricker technique) or a conjoined end-to-end anastomosis (Wallace technique). The distal conduit is usually matured as a protruding, everted stoma in the right lower quadrant for reliable appliance drainage.

Colonic Conduit (Transverse or Sigmoid) : An option when ileum is unsuitable and a healthy, well-vascularized colonic segment is available. Prior radiation or inflammatory bowel disease requires assessment of the actual bowel involved; neither automatically makes colon a safe substitute.

Continent Cutaneous Diversions

Indiana Pouch : Incorporates 10 to 12 cm of terminal ileum and the cecum/ascending colon up to the hepatic flexure. The colonic segment is detubularized along the antimesenteric border and folded to construct a high-capacity, low-pressure spherical pouch. Continence is provided by the plicated, reinforced ileocecal valve and tapered terminal ileum, which is brought out as a small, flush, catheterizable cutaneous stoma (typically at the umbilicus). Patients perform clean intermittent self-catheterization every 4 to 6 hours.

Orthotopic Neobladder Reconstruction

Surgical Concept : An isolated detubularized intestinal segment is configured into a compliant, spherical, low-pressure neo-reservoir positioned in the anatomically orthotopic pelvic location and anastomosed directly to the native urethral stump.

Common Neobladder Techniques :

Studer Neobladder : Employs 54 to 60 cm of ileum. The distal 40 to 44 cm is detubularized and folded into a sphere; the proximal 12 to 16 cm is kept tubularized as an isoperistaltic afferent limb to which both spatulated ureters are anastomosed end-to-side, providing an anti-reflux mechanism without requiring tunneling.

Hautmann Neobladder : Employs 60 cm of detubularized ileum configured into a W-pouch with sub-mucosal tunnelled (le Duc) ureteric implantation.

Voiding Physiology : Normal detrusor contractility is absent. Micturition is achieved by conscious voluntary pelvic floor and external urethral sphincter relaxation , coupled with sustained Valsalva maneuver (abdominal straining) . Nocturnal leakage is common: altered filling sensation, reservoir contractions and reduced outlet resistance during sleep contribute. Normal spinal bulbocavernosus reflex arcs are not inherently abolished by neobladder construction.

4. Patient Selection & Contraindications for Orthotopic Neobladders

Orthotopic reconstruction carries significant metabolic, psychological, and physiological demands. Patient selection must be rigorous:

Absolute Contraindications

Positive Distal Urethral Margin : Identification of invasive urothelial carcinoma or carcinoma in situ (CIS) on intraoperative frozen section at the urethral transection margin. Do not anastomose the reservoir to an involved margin; manage the urethral disease and choose an oncologically safe diversion.

Inability or Unwillingness to Perform Clean Intermittent Self-Catheterization (CISC) : Incomplete emptying and urinary retention (hypercontinence) may require catheterization, especially in women; reported rates depend strongly on technique, follow-up and definitions. Severe cognitive impairment, psychiatric instability, manual dexterity loss (advanced Parkinson's disease, severe rheumatoid arthritis), or refusal to catheterize are absolute contraindications.

Severe Renal Impairment : Severely impaired renal function limits excretion of the additional acid load absorbed from urine by the bowel reservoir. Assess renal reserve, acid-base status and ability to sustain follow-up; EAU does not define GFR 45–50 mL/min as a universal absolute cutoff. Selected CKD stage 3a patients (GFR 45–59) may remain suitable.

Severe Hepatic Impairment : Advanced liver disease or cirrhosis (Child-Pugh B or C). Reabsorbed urinary ammonium cannot be converted to urea by a failing liver, triggering hyperammonemic hepatic encephalopathy.

Relative Contraindications

Prior High-Dose Pelvic Radiotherapy : Can impair tissue healing, bowel suitability and sphincter function, increasing reconstructive risk. It is a relative contraindication requiring individual assessment, rather than an assurance of permanent total incontinence.

Active Inflammatory Bowel Disease (IBD) : Crohn's disease or active ulcerative colitis carrying risks of pouch perforation, chronic fistulization, and progressive bowel loss.

Bladder Neck Infiltration in Females or Prostatic Urethral Infiltration in Males : Extensive tumor involvement extending into the female bladder neck or prostate stroma at the apex raises the risk of positive urethral margins.

5. Metabolic and Long-Term Complications of Urinary Diversions

Incorporating intestinal segments into the urinary tract creates chronic metabolic derangements caused by active solute and water transport across the gut epithelium. ┌────────────────────────────────────────────────────────────────────────┐

  • │ INTESTINAL SOLUTE TRANSPORT │
  • ├────────────────────────────────────┬───────────────────────────────────┤
  • │ ILEUM / COLON SEGMENT │ GASTRIC SEGMENT │
  • ├────────────────────────────────────┼───────────────────────────────────┤
  • │ • Secretes HCO3- │ • Secretes H+ and Cl- │
  • │ • Absorbs Cl-, NH4+, and H+ │ • Net loss of gastric acid │
  • │ │ │
  • │ ▼ │ ▼ │
  • │ HYPERCHLOREMIC METABOLIC │ HYPOKALEMIC HYPOCHLOREMIC │
  • │ ACIDOSIS (Normal Anion Gap) │ METABOLIC ALKALOSIS │
  • └────────────────────────────────────┴───────────────────────────────────┘
  • Solute Transport & Acid-Base Physiology

Ileal and Colonic Diversions :

The apical membrane C l − / H C O 3 − Cl^-/HCO_3^- C l − / H C O 3 − ​ exchanger actively absorbs luminal chloride ( C l − Cl^- C l − ) in exchange for intracellular bicarbonate ( H C O 3 − HCO_3^- H C O 3 − ​ ).

Urinary ammonium ( N H 4 + NH_4^+ N H 4 + ​ ) is reabsorbed, contributing to a net acid load; hydrogen/chloride uptake and bicarbonate secretion further alter acid-base balance.

Clinical Derangement : Hyperchloremic, normal anion gap metabolic acidosis associated with mild hypokalemia.

Management : Administration of oral alkalinizing agents ( sodium bicarbonate 1–2 g TID or potassium citrate ). Avoid excessive chloride loading; balanced crystalloids are often preferable when intravenous replacement is needed. Select fluids according to volume status, electrolytes and renal function rather than prohibiting saline in every circumstance.

Gastric Diversions (Gastrocystoplasty) :

Gastric mucosa secretes hydrochloric acid into urine, causing net loss of hydrogen and chloride from the body.

Clinical Derangement : Hypokalemic, hypochloremic metabolic alkalosis accompanied by dysuria-hematuria syndrome from caustic acid contacting the native urethra. Managed with proton pump inhibitors (PPIs) and intravenous volume repletion with saline.

Nutritional & Hematological Complications

Vitamin B12 (Cobalamin) Deficiency :

The terminal ileum is the principal site of intrinsic factor-mediated vitamin B12 absorption; the length and health of the remaining ileum influence malabsorption risk.

Extensive distal ileal resection increases malabsorption risk. Hepatic cobalamin stores may delay presentation for several years. Deficiency can cause insidious macrocytic megaloblastic anemia and irreversible subacute combined degeneration of the spinal cord (posterior and lateral column demyelination presenting with ataxia, paresthesias, and loss of proprioception/vibration sense).

Mandatory Practice : Measure B12 annually after bowel diversion. Treat deficiency promptly with appropriate loading followed by maintenance replacement; use parenteral treatment when significant malabsorption or neurological features warrant it. A monthly maintenance schedule alone is not initial treatment for neurological deficiency.

Bile Acid Malabsorption & Chologenic Diarrhea : Loss of terminal ileal apical sodium-dependent bile acid transporters allows unabsorbed bile salts to reach the colon, stimulating colonic secretory diarrhea and impairing micellar solubilization of fat-soluble vitamins (A, D, E, K).

Bone Demineralization : Chronic buffering of uncorrected metabolic acidosis leads to bone calcium carbonate resorption, precipitating osteopenia, osteomalacia, hypercalciuria, and secondary osteoporosis.

Mechanical & Anastomotic Complications

Ureteroenteric Anastomotic Strictures : Occur in 3% to 10% of cases, most commonly on the left side due to extensive mobilization under the sigmoid mesentery causing chronic ischemia. Leads to silent, progressive renal atrophy. Evaluated with loopography, CT urography, and renography; managed with endoscopic balloon dilation/stenting or surgical revision.

Reservoir Calculi : Occur in up to 10% of continent pouches and neobladders. Form around foreign bodies (surgical staples), accumulated mucus nidi, or persistent infection with urea-splitting organisms ( Proteus , Klebsiella ). Prevention focuses on adequate hydration, complete emptying and regular irrigation to clear mucus when appropriate; routine oral N-acetylcysteine has no established preventive benefit.

6. Urinary Diversion Comparison Table

Diversion Type Bowel Segment Used Continence Status Characteristic Metabolic Derangement Common Late Complications & Key Considerations

Ileal Conduit (Bricker) 15–20 cm of terminal ileum (isolated 15 cm proximal to IC valve) Incontinent (Requires external ostomy appliance) Hyperchloremic, normal anion gap metabolic acidosis Parastomal hernia (15–25%), stomal stenosis, ureteroenteric stricture (3–5%), chronic pyelonephritis. Established option; frail patients may instead benefit from simpler ureterocutaneostomy.

Colonic Conduit 15–20 cm of sigmoid or transverse colon Incontinent (External ostomy appliance) Hyperchloremic metabolic acidosis Stomal retraction, colonic diverticulitis. Consider if healthy colon is available and ileum is unsuitable; assess radiation distribution.

Indiana Pouch Detubularized cecum, ascending colon + tapered ileum stoma Continent Cutaneous (Clean intermittent self-catheterization) Hyperchloremic metabolic acidosis Stomal stenosis (5–10%), pouch calculi (10%), incontinence at plicated valve, catheterization difficulties.

Orthotopic Neobladder (Studer / Hautmann) 54–60 cm of detubularized ileum Continent Orthotopic (Micturition via native urethra) Hyperchloremic metabolic acidosis; vitamin B12 deficiency from ileal malabsorption Daytime/nocturnal leakage, retention requiring CISC (especially in women), and neobladder stones; rates vary with technique and follow-up.

Gastrocystoplasty Gastric wedge based on gastroepiploic arcade Continent or augmentation Hypokalemic, hypochloremic metabolic alkalosis Dysuria-hematuria syndrome (peptic ulceration of urothelium), severe electrolyte collapse during vomiting; rarely used in modern urology.